CD34 and hematologic disorder: No association was found between median elafin levels and clinical variables such as age, sex, stem cell source, donor sex, hematological malignancy, disease status at transplant, HSCT–associated comorbidity, previous transplant, conditioning regimen intensity, and number of infused CD34+ cells (data not shown).